Why Meridian Bioscience's Shares Are Rising Today?

View more earnings on VIVO

See more from Benzinga

• Delcath's Chemosat Hepatic Delivery System Shows Overall Response Rate Of 60.5% In Eye Cancer That Spreads To Liver

• Valneva - Pfizer Choose Three-Dose Schedule For Lyme Vaccine Candidate Moving Forward

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.